Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Dispatch Volumes of Pharmaceutical Drugs from Russian Manufacturers (December 2016)

Tuesday, January 31, 2017

In 2016, Russian manufacturers produced and dispatched 314.5 bln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is in monetary terms 23.7% higher than that of 2015 and is way above the average performance. In physical terms, the dispatch volumes have risen by 7.6% over the year, with 4.3 bln units of pharmaceuticals.

In December, Russian manufacturers were not that active, though they still followed the season’s trends. The best performance was seen in April, June, and October. In December, Russian manufacturers produced and dispatched 29.5 bln RUB worth of pharmaceutical drugs, which is 22% higher than that of December 2015. This is, however, not the best result of 2016, only three months had worse performance.

As for the import of pharmaceuticals, the increase in monetary terms was 8.6% in December, while the increase in the in-bulk import was 15.3%, which is not comparable to the growth rates of the Russian pharmaceutical production.

Dynamics of dispatch volumes of pharmaceutical drugs from Russian manufacturers, in physical (units) and monetary terms (RUB, VAT included) (January 2015 – December 2016)

Share: